Investing in Healthcare: A Comparison of iShares U.S. Pharmaceuticals ETF and iShares U.S. Healthcare ETF

The healthcare sector has been a significant performer in recent years, driven by advancements in medical technology and an aging global population. Two popular exchange-traded funds (ETFs) that offer exposure to this sector are the iShares U.S. Pharmaceuticals ETF (IHE) and the iShares U.S. Healthcare ETF (IYH). Both funds are managed by iShares, a division of BlackRock Inc, and have similar expense ratios of 0.37%. However, they differ significantly in their scope and investment approach.

Investment Approach and Holdings

The iShares U.S. Pharmaceuticals ETF (IHE) offers concentrated exposure to the drug manufacturing industry, with 55 holdings specifically within this space. Its top holdings include Johnson & Johnson (22.5%), Eli Lilly (20.5%), and Merck & Co Inc (5%). In contrast, the iShares U.S. Healthcare ETF (IYH) provides a broader basket covering medical providers, devices, and biotechnology, with 100 stocks across the domestic medical spectrum. Its largest positions include Eli Lilly & Co (14.5%), Johnson & Johnson (10%), and Abbvie Inc (7.1%).

Performance Comparison

When it comes to performance, the iShares U.S. Pharmaceuticals ETF (IHE) has been the clear winner in recent years. Over the 3-, 5-, and 10-year time periods, IHE has produced annualized returns of 19.9%, 11.9%, and 9.3%, respectively. In contrast, the iShares U.S. Healthcare ETF (IYH) has produced annualized returns of 10%, 5.5%, and 10.5% over the same periods. While IYH has beaten IHE over the past decade, IHE's consistent recent performance makes it the better choice for investors seeking long-term growth.

Key Metrics and Comparison

Here are some key metrics and comparisons between the two ETFs:
  • Share price: IHE ($104.73) vs. IYH ($72.63)
  • Expense ratio: 0.37% for both ETFs
  • 1-year return: IHE (50.0%) vs. IYH (27.4%)
  • Dividend yield: IHE (1.4%) vs. IYH (1.1%)
  • Beta: IHE (0.49) vs. IYH (0.58)
  • AUM: IHE ($1.8B) vs. IYH ($3.9B)

Conclusion and Next Steps

In conclusion, while both the iShares U.S. Pharmaceuticals ETF (IHE) and the iShares U.S. Healthcare ETF (IYH) offer exposure to the healthcare sector, IHE's concentrated approach and consistent recent performance make it the better choice for investors seeking long-term growth. However, it's essential to consider individual investment goals and risk tolerance before making a decision. As the healthcare sector continues to evolve, it's crucial to stay informed about the latest developments and trends in the industry.